MedTrace Logo

Clinical and Pathologic Studies in Neuroendocrine Tumors

NCT00657332 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-11-28

No results posted yet for this study

Summary

This research involves the study of neuroendocrine tumors in order to better understand how the disease grows and spreads. This study requires will use tissue collected from from biopsies performed during your regular medical care (i.e. tissue leftover after your diagnosis has been made) and/or blood and urine samples. This study may lead to the development of special materials that could be used, in the future, to treat neuroendocrine tumors or to follow the response of neuroendocrine tumors to treatment

Conditions

Interventions

PROCEDURE

blood sample draw

PROCEDURE

urine sample

Sponsors & Collaborators

Principal Investigators

  • George Albert Fisher M.D. Ph.D. · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-06-17
Completion
2008-06-17

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00657332 on ClinicalTrials.gov